Your browser doesn't support javascript.
3CLpro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials.
Sisay, Mekonnen.
  • Sisay M; Department of Pharmacology and Toxicology, School of Pharmacy, College of Health and Medical Sciences, Haramaya University, P.O. Box, 235, Harar, Ethiopia. Electronic address: mekonnensisay27@yahoo.com.
Pharmacol Res ; 156: 104779, 2020 06.
Article in English | MEDLINE | ID: covidwho-26870

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Protease Inhibitors / Clinical Trials as Topic / Viral Nonstructural Proteins / Coronavirus Infections / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Protease Inhibitors / Clinical Trials as Topic / Viral Nonstructural Proteins / Coronavirus Infections / Betacoronavirus Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2020 Document Type: Article